Brian Regan is a general partner of Welsh, Carson, Anderson & Stowe (“WCAS”), where he focuses on health care investments. He serves on the boards of directors of US Anesthesia Partners, Springstone and Aptuit. Brian has also been involved in current and former WCAS investments in NEWAsurion, Smile Brands, Laurus Labs, Ardent Health Services, Bausch & Lomb, Select Medical, MultiPlan/Viant, Concentra and Ruesch International. Before joining WCAS in 2002, he worked in the investment banking division of Merrill Lynch. Brian graduated from Yale College.